Stryker Corporation (SYK)
Data as of Nov 3, 11:22 AM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
SYK key stats
SYK GlowScore: Active
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
What's moving SYK today
Updated November 3, 2026As of November 3, 2026, Stryker Corporation (SYK) stock rose to $311.71, up 1.60% (+$4.90) versus the previous close. On the day, shares have traded between $306.41 and $312.74. That puts SYK around the middle of its 52-week range of $267.00 to $389.33. Stryker Corporation operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $117.68 billion, with about 774.6K shares changing hands.
Latest SYK news
- Is Intuitive Surgical Stock Worth More Than Its Competitors?trefis.com· Nov 3, 8:39 AM ET
- Why Did Boston Scientific Stock Jump?trefis.com· Nov 3, 7:41 AM ET
- A Memo To Stryker's Orthopaedics Team About Winning Againtrefis.com· Nov 3, 7:17 AM ET
- Pulmera Names Gina Giambalvo Vice President of Market DevelopmentYahoo Finance· Nov 2, 12:34 PM ET
- Is This Number The Biggest Risk To Intuitive Surgical Stock?trefis.com· Nov 2, 3:35 AM ET
- What Sent ResMed Stock Lower?trefis.com· Nov 1, 8:23 PM ET
- SYK Q3 deep dive: Orthopedics softness, margin pressure, and product launches shape outlookYahoo Finance· Oct 31, 10:51 PM ET
- Stryker (SYK) Stock Fair Value Falls After Analysts Reset Expectations Following Q3 GuidanceYahoo Finance· Oct 31, 8:19 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want SYK headlines, alerts and AI research in one place? Create a free account →
SYK buzz on Stocktwits
4,513 watchersNice win in $SYK today. I think I’ll play this for awhile, need to study the covered call market. Can’t stand making too much here.
@Parmesan· Nov 3, 12:20 AM ET
Something's going on under the surface in $SYK: off-exchange volume hit about 000x normal. That came on a day the stock dropped hard, so the question is whether big holders were buying the dip or heading for the exit. The options side leaned puts the same day. $SPY $QQQ Si…
@GlobalTradersAcademy· Nov 2, 8:05 PM ET
$SYK The 293 million dollar goodwill impairment in Q3 came from one reporting unit. Note 11 puts it in Peripheral Vascular, after forecast cash flows were cut on near-term operational and supply constraints and a longer expected period to reach the anticipated growth. That uni…
@KryptonResearch14· Oct 31, 2:38 PM ET
$SYK Bought 150 shares for my son in his account and 200 shares for myself. What a great bargain!
@Orbit100· Oct 30, 1:44 PM ET· Bullish
$SYK down about 13% after hours. Stryker is medtech, not even an AI stock, and it still lost double digits after hours. this selloff is not checking tickers
@thatsolardude365· Oct 30, 4:33 AM ET
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
SYK Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on SYK
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.